Indeed, the scientific added value of quantifying the expression of the FCGRT gene separately between cancer‐ and noncancer cells is only as recent as the aforementioned literature involving FcRn in tumor immunosurveillance. The gene discussed is FCGRT; the disease is neoplasm.